Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of ivabradine versus placebo on cardiac function, exercise capacity, and neuroendocrine activation in patients with Chronic Heart Failure with Preserved left ventricular Ejection Fraction An 8-month, randomised double-blind, placebo controlled, international, multicentre study.

Next Previous
X
Search
Trial Profile

Effect of ivabradine versus placebo on cardiac function, exercise capacity, and neuroendocrine activation in patients with Chronic Heart Failure with Preserved left ventricular Ejection Fraction An 8-month, randomised double-blind, placebo controlled, international, multicentre study.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jun 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ivabradine (Primary)
  • Indications Chronic heart failure
  • Focus Proof of concept; Therapeutic Use
  • Acronyms EDIFY
  • Sponsors IRIS; Servier

    • Most Recent Events

    • 30 Apr 2017 Primary endpoint (Echo-Doppler E/e ratio) has not been met, according to the results published in the European Journal of Heart Failure
    • 30 Apr 2017 Primary endpoint (B-type natriuretic peptide levels (NT-proBNP)) has not been met, according to the results published in the European Journal of Heart Failure
    • 30 Apr 2017 Primary endpoint (Six-minute walking distance) has not been met, according the results published in the European Journal of Heart Failure

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top